Expertise in
37
conditions

Dr. Joseph Merola

Dermatology | Internal Medicine
5939 Harry Hines Blvd Pob 2 4th Fl # 100, 
Dallas, TX 
Expertise in
37
conditions
5939 Harry Hines Blvd Pob 2 4th Fl # 100, 
Dallas, TX 

Overview

Joseph Merola is a Dermatologist and an Internal Medicine provider practicing medicine in Dallas, Texas.

Dr. Merola is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Psoriasis, Cutaneous Lupus Erythematosus (CLE), Psoriatic Arthritis, and Arthritis.

He is actively involved in clinical research, co-authoring 426 peer reviewed articles and participating in 8 clinical trials.

Specialties

Dermatology
Internal Medicine

Licenses

Dermatology in MA

Hospital Affiliations

Parkland Health & Hospital System
UT Of Texas Southwestern University Hospital - William P. Clements Jr.

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cook Children's Health Plan
  • MANAGED MEDICAID PLAN
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

5939 Harry Hines Blvd Pob 2 4th Fl # 100, Dallas, TX 75390
Other Locations
221 Longwood Ave, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Pro-Resolving Mediators in Acute Inflammation in Humans
Pro-Resolving Mediators in Acute Inflammation in Humans
Enrollment Status: Completed
Publish Date: May 26, 2022
Intervention Type: Other, Drug
Study Drug: Lovaza
Study Phase: Early Phase 1
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Enrollment Status: Terminated
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

426 Total Publications

International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement.
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement.
Journal: JAMA dermatology
Published: April 15, 2026
Similar Doctors
Expertise in
30
conditions
Dr. Melissa Mauskar
Dermatology
Expertise in
30
conditions
Dr. Melissa Mauskar
Dermatology
5939 Harry Hines Blvd, 
Dallas, TX 
 (0.1 miles away)
214-648-3111
Languages Spoken:
English
See accepted insurances

Melissa Mauskar is a Dermatologist practicing medicine in Dallas, Texas. Dr. Mauskar is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Lichen Sclerosus, Erythema Multiforme, Lichen Planus, and Stevens-Johnson Syndrome.

Expertise in
27
conditions
Dr. Benjamin Chong
Dermatology
Expertise in
27
conditions
Dr. Benjamin Chong
Dermatology
5939 Harry Hines Blvd Pob 2 4th Fl # 100, 
Dallas, TX 
 (0.3 miles away)
214-648-3111
Languages Spoken:
English
See accepted insurances

Benjamin Chong is a Dermatologist practicing medicine in Dallas, Texas. Dr. Chong is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), Systemic Lupus Erythematosus (SLE), and Dermatomyositis.

Expertise in
10
conditions
Dr. Heidi Jacobe
Dermatology
Expertise in
10
conditions
Dr. Heidi Jacobe
Dermatology
5939 Harry Hines Blvd # 100, 
Dallas, TX 
 (1.1 miles away)
214-645-2400
Languages Spoken:
English
See accepted insurances

Heidi Jacobe is a Dermatologist practicing medicine in Dallas, Texas. Dr. Jacobe is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Localized Scleroderma, Scleroderma, Systemic Sclerosis (SSc), and Scleroma.

Frequently Asked Questions about Dr. Joseph Merola

How do I make an appointment with Dr. Joseph Merola?

You can book an appointment with Dr. Joseph Merola by calling their office at 469-291-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joseph Merola a top-rated expert for Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph Merola is classified as an Elite expert for Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joseph Merola specialize in?

While Dr. Joseph Merola is a Dermatology, they have specific expertise in Psoriasis, Cutaneous Lupus Erythematosus (CLE), and Psoriatic Arthritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Joseph Merola participate in research or clinical trials?

Yes. Dr. Joseph Merola has published 426 articles and abstracts on conditions like Psoriasis. You can view a list of Dr. Joseph Merola's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joseph Merola accept my insurance?

Dr. Joseph Merola accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 469-291-2000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Merola's expertise for a condition
ConditionClose
View All 11 Elite Conditions
View All 23 Advanced Conditions
View All 125 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile